Olvanil

Olvanil

SCHEMBL94262

CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(O)c(OC)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 7/20 1.00
HPGD P15428 3/20 1.00
MAPT P10636 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP3A4 P08684 2/20 1.00
CYP2D6 P10635 2/20 1.00
MEN1 O00255 1/20 1.00
TP53 P04637 1/20 1.00
MTOR P42345 1/20 1.00
KMT2A Q03164 1/20 1.00
ALDH1A1 P00352 2/20 0.90
CYP2C9 P11712 1/20 0.87
ALOX15 P16050 1/20 0.87
CYP2C19 P33261 1/20 0.87
BLM P54132 1/20 0.87
PMP22 Q01453 1/20 0.87
EPHX2 P34913 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10835242 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
SCHEMBL10710550 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
SCHEMBL10711981 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
Olvanil SCHEMBL557179 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
Olvanil SCHEMBL537603 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
SCHEMBL10713542 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
SCHEMBL10711036 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
Olvanil SCHEMBL29381897 1.00 TRPV1 (1.00) TRPV1HPGDMAPTCYP1A2CYP3A4
SCHEMBL10883574 0.98 TRPV1 (0.96) TRPV1HPGDMAPTCYP1A2CYP3A4
SCHEMBL10885299 0.98 TRPV1 (0.96) TRPV1HPGDMAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2069 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4683527-A1 VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF Ready Mix Naturals, LLC (US) 2026-01-28 EP claimed
EP-4680210-A1 MEDICAL PATCH COMPRISING SKIN IRRITATING ACTIVE AGENT LTS Lohmann Therapie-Systeme AG (DE) 2026-01-21 EP claimed
US-12497381-B2 Vaporizable alkaloid compositions and methods of use thereof Ready Mix Naturals, LLC (US) 2025-12-16 US claimed
US-20250360137-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES FREEDOM BIOSCIENCES INC (US) 2025-11-27 US claimed
US-12478091-B2 Vaporizable alkaloid compositions and methods of use thereof Ready Mix Naturals, LLC (US) 2025-11-25 US claimed
EP-4618980-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES Freedom Biosciences, Inc. (US) 2025-09-24 EP claimed
US-20250289796-A1 COMPOSITIONS AND METHODS OF USE THEREOF Ready Mix Naturals, LLC (US) 2025-09-18 US claimed
US-12358888-B2 Vaporizable alkaloid compositions and methods of use thereof Ready Mix Naturals, LLC (US) 2025-07-15 US claimed
US-12358889-B2 Vaporizable alkaloid compositions and methods of use thereof Ready Mix Naturals, LLC (US) 2025-07-15 US claimed
EP-2222289-B2 TREATMENT OF ORAL PHARYNGEAL DYSPHAGIA NESTLE SA (CH) 2025-05-14 EP claimed
EP-1003491-A1 USE OF ANTAGONISTS OR PARTIAL AGONISTS OF THE VANILLOID RECEPTOR COMPLEXES FOR TREATING NEURODEGENERATIVE DISEASES SMITHKLINE BEECHAM PLC (GB) 2000-05-31 EP claimed
WO-2000016756-A2 USE OF N-ACYLVANILLINAMIDE DERIVATIVES AS AGONISTS OF PERIPHERAL CANNABINOID CB1 RECEPTORS INNOVET ITALIA S.R.L. (IT) 2000-03-30 WO claimed
WO-1999000115-A1 USE OF ANTAGONISTS OR PARTIAL AGONISTS OF THE VANILLOID RECEPTOR COMPLEXES FOR TREATING NEURODEGENERATIVE DISEASES SMITHKLINE BEECHAM PLC (GB) 1999-01-07 WO claimed
US-5762963-A DISPERSING IN SOLID OR GEL VEHICLE IN WHICH CONCENTRATION OF CAPSAICINOID DECREASES FROM CENTER TOWARD PERIPHERY; FOR MOUTH, THROAT PAIN RELIEF EMORY UNIVERSITY (US) 1998-06-09 US claimed
WO-1996040079-A1 METHOD AND COMPOSITIONS FOR CONTROLLING ORAL AND PHARYNGEAL PAIN USING CAPSAICINOIDS EMORY UNIVERSITY (US) 1996-12-19 WO claimed
EP-0149544-B1 PHARMACEUTICAL PRODUCTS PROVIDING ENHANCED ANALGESIA THE PROCTER & GAMBLE COMPANY (US) 1989-09-13 EP claimed
EP-0132113-B1 COMPOSITIONS USEFUL FOR PRODUCING ANALGESIA THE PROCTER & GAMBLE COMPANY (US) 1988-10-26 EP claimed
US-4681897-A CAPSAICIN OR ANALOGUE WITH A NONSTEROIDAL ANALGESIC THE PROCTER & GAMBLE COMPANY (US) 1987-07-21 US claimed
EP-0132113-A1 Compositions useful for producing analgesia THE PROCTER & GAMBLE COMPANY (US) 1985-01-23 EP claimed
US-4493848-A N-((SUBSTITUTED PHENYL)METHYL)CIS MONOUNSATURATED ALKENAMIDE) THE PROCTER & GAMBLE COMPANY (US) 1985-01-15 US claimed